![Gordon Brooks](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Gordon J.
Brooks currently works at Dermira, Inc., as Director from 2020, ARMO BioSciences, Inc., as Director from 2018, and Sigilon Therapeutics, Inc., as Director from 2023.
Gordon Brooks active positions
| Companies | Position | Start |
|---|---|---|
| ARMO BIOSCIENCES INC | Director/Board Member | 21/06/2018 |
| DERMIRA, INC. | Director/Board Member | 20/02/2020 |
| SIGILON THERAPEUTICS, INC. | Director/Board Member | 11/08/2023 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
48
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Dermira, Inc.
 Dermira, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products to patients living with chronic skin conditions | Health Technology |
ARMO BioSciences, Inc.
 ARMO BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapy for treatment of cancer | Health Technology |
Sigilon Therapeutics, Inc.
 Sigilon Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics and functional cures for patients with chronic diseases | Health Technology |
- Stock Market
- Insiders
- Gordon Brooks
